IsoRay, Inc.
(AMEX:ISR)|
0.290 -0.030 (-9.38%) Jan 07 - Close |
|
|
|
After-Hours 0.30 +0.01 (3.45%) Wed, 7 Jan 2009 7:40 PM
- Compare ISR with:
- View: Line | Candlestick
Company Profile
IsoRay, Inc.
350 Hills Street
Richland, WA 99354
United States - Map
Phone: (509) 375-1202
Fax: (509) 375-3473
Website: www.isoray.com
State of incorporation: Minnesota
CEO: Dwight Babcock
Employees: 49
Sector: Healthcare
Industry Group: Health Services
Industry: Medical Instruments & Supplies
Makes isotopes for seed brachytherapy cancer.
The Company develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases, through its subsidiary.
Recent news for ISR
-
EDGAR Online Financials - Dec 20 2008 at 9:04 ET
-
ISORAY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online - Dec 12 2008 at 5:07 ET
-
EDGAR Online Financials - Dec 05 2008 at 9:04 ET
-
IsoRay Hires New VP of Business Development in Charge of Sales
Business Wire - Nov 24 2008 at 8:30 ET
-
New Star Analyst Rankings for ISORAY INC
StarMine - Nov 16 2008 at 9:33 ET
-
ISORAY, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 14 2008 at 1:24 ET
-
New Star Analyst Rankings for ISORAY INC
StarMine - Nov 14 2008 at 9:23 ET
-
EDGAR Online - Nov 13 2008 at 12:33 ET
-
IsoRay, Inc. Reports First Quarter Results
Business Wire - Nov 13 2008 at 7:30 ET
-
IsoRay Inc. Announces First Quarter Earnings Release Date and Conference Call
Business Wire - Nov 06 2008 at 8:04 ET
Member sentiment (?) Neutral
Top members owning ISR
-
Top 93%
-2.65%
-
Top 3%
+3.15%
* Average monthly return vs. S&P 500